EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel Pathogenic Variants in POLR3K Cause POLR3‐Related Leukodystrophy

Stefanie Perrier iD, Julia Macintosh iD, Agata D Misiaszek iD, Gabrielle Lambert, Kether Guerrero iD, Luan T Tran iD, Christoph W Müller iD, Tomi Pastinen iD, Gustavo H B Maegawa iD, Isabelle Thiffault iD, Geneviève Bernard iD

Human Mutation · 2024

DOI: 10.1155/2024/8807171 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Mutation, 2024. Verfasst von Stefanie Perrier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery McGill University, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: RNA Polymerase III, Hereditary Central Nervous System Demyelinating Diseases, Genetic Predisposition to Disease, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Molecular Biology Laboratory, McGill University Health Centre, Fondation du Grand défi Pierre Lavoie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

POLR3‐related hypomyelinating leukodystrophy (POLR3‐HLD) is a rare inherited neurological disorder caused by biallelic pathogenic variants in specific genes encoding subunits of RNA polymerase III (Pol III). Here, we report the third patient worldwide with pathogenic variants in POLR3K and clinical features consistent with POLR3‐HLD. The female patient presented with mild intellectual and behavioural disturbances in childhood, as well as growth delay, with brain MRI revealing diffuse hypomyelination and a pattern consistent with POLR3‐HLD. In adolescence, she manifested minor motor dysfunction. Next‐generation sequencing revealed a paternally inherited missense variant in POLR3K (c.322G>T; p.D108Y) and a maternally inherited large deletion, spanning approximately 17.8 kb from chr16:30,362‐48,162. The missense variant is located at the C‐terminus position of the protein and is predicted to impair residue interactions and cause steric interference in enzyme conformational changes. The large deletion encompasses the third and last exon of POLR3K , leading to a likely amorphic truncated protein product lacking the final 42 amino acids from the total 108 amino acid–length protein. Studies of RNA‐level expression showed a significant reduction in the levels of POLR3K RNA in the patient compared to the control. In considering whether the transcriptional function of Pol III was affected, the expression of several Pol III‐transcribed RNAs was measured, where the levels of several distinct tRNAs were significantly reduced in the patient while the expression of other RNA transcripts was not decreased, suggesting that Pol III retains partial function. This study provides further evidence for the association of pathogenic variants in POLR3K with POLR3‐HLD, expanding the spectrum of pathogenic variants in genes encoding for Pol III subunits associated with this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IIIHereditary Central Nervous System Demyelinating DiseasesGenetic Predisposition to DiseaseMutationHumansFemaleMutation, MissenseMagnetic Resonance ImagingAdolescentPhenotypeGenetic Association StudiesPedigree

Stichwörter der Autor:innen

POLR3-related leukodystrophyPOLR3KPol IIIRNA polymerase IIIRPC10case reporthypomyelination

Substanzen

RNA Polymerase III

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery McGill University, Montréal, Quebec, Canada.
  • Child Health and Human Development Program Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
  • Structural and Computational Biology Unit European Molecular Biology Laboratory, Heidelberg, Germany.
  • Faculty of Biosciences Heidelberg University, Heidelberg, Germany.
  • Department of Pediatrics McGill University, Montréal, Quebec, Canada.
  • Genomic Medicine Center Children's Mercy Hospital, Kansas City, Missouri, USA.

ORCID-Profile: Stefanie Perrier, Julia Macintosh, Agata D Misiaszek, Kether Guerrero, Luan T Tran, Christoph W Müller, Tomi Pastinen, Gustavo H B Maegawa, Isabelle Thiffault, Geneviève Bernard

Förderung

  • European Molecular Biology Laboratory
  • McGill University Health Centre
  • Fondation du Grand défi Pierre Lavoie
  • Canadian Institutes of Health Research

Zitieren

APA

Perrier, S., Macintosh, J., Misiaszek, A. D., Lambert, G., Guerrero, K., Tran, L. T., Müller, C. W., Pastinen, T., Maegawa, G. H. B., Thiffault, I., & Bernard, G. (2024). Novel Pathogenic Variants in POLR3K Cause POLR3‐Related Leukodystrophy. Human Mutation. https://doi.org/10.1155/2024/8807171

Vancouver

Perrier S, Macintosh J, Misiaszek AD, Lambert G, Guerrero K, Tran LT, et al. Novel Pathogenic Variants in POLR3K Cause POLR3‐Related Leukodystrophy. Human Mutation. 2024. doi:10.1155/2024/8807171

BibTeX
@article{Perrier2024,
  author = {Perrier, Stefanie and Macintosh, Julia and Misiaszek, Agata D and Lambert, Gabrielle and Guerrero, Kether and Tran, Luan T and Müller, Christoph W and Pastinen, Tomi and Maegawa, Gustavo H B and Thiffault, Isabelle and Bernard, Geneviève},
  title = {Novel Pathogenic Variants in POLR3K Cause POLR3‐Related Leukodystrophy},
  journal = {Human Mutation},
  year = {2024},
  doi = {10.1155/2024/8807171}
}
Kostenlos starten →